Beximco Pharmaceuticals Limited., the leading manufacturer and exporter of medicines in Bangladesh, has recently received GMP (Good Manufacturing Practices) approval from the Canadian regulatory authority, Health Canada, according to a statement.
This is for the first time a Bangladeshi company has received this prestigious approval. This opens a new marketing opportunity for Beximco Pharma in the Canadian market and, similar to many other developed countries, Canada is increasingly promoting access to generic drugs. In July this year, Beximco Pharma also received GMP approval from the Taiwan Food & Drug Authority (TFDA), again marking a first time approval for a Bangladeshi company.
Nazmul Hassan MP, Managing Director of Beximco Pharma, said, "Canada is an important market for us and this approval marks a significant milestone for the Company, further validating our high standards of quality and compliance practices. This approval builds on our existing presence in key regulated markets and is an important step towards our aspiration to become a global generic drug player.''
Beximco Pharma receives approval from Health Canada
FE Team | Published: November 24, 2014 00:00:00 | Updated: November 30, 2026 06:01:00
Share if you like